Local News: Robbins, CA 

 | 

Sign Up

 | 

Sign In

Advertisment

Ranbaxy Laboratories

Ranbaxy Laboratories News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Ranbaxy Laboratories News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Ranbaxy Laboratories News

News on Ranbaxy Laboratories continually updated from thousands of sources around the net.

Monday | The Hindu

Ranbaxy to make presence in African region

CHENNAI: Daiichi Sankyo Company and Ranbaxy Laboratories have announced that Ranbaxy will launch Olmesartan Medoxomil, an anti-hypertensive, originally discovered by Daiichi Sankyo in six African countries.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Wed Dec 16, 2009

Express India

Ranbaxy arm set to shed Orchid stake

R Ravichandran Posted: Thursday, Dec 17, 2009 at 0406 hrs IST Updated: Thursday, Dec 17, 2009 at 0406 hrs IST Chennai: Solrex Pharmaceuticals, a wholly owned subsisidiary of Ranbaxy Laboratories, is planning to exit Chennai-based Orchid Chemicals & Pharmaceuticals Ltd, in which it holds little over 13.7% stake.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Thu Dec 10, 2009

Business Standard

Fortis in talks to buy Lanka hospital chain

Move comes within months of acquiring Wockhardt hospitals. Fortis Healthcare, a hospital chain promoted by former Ranbaxy owners Malvinder Mohan Singh and Shivinder Mohan Singh, is close to a major acquisition overseas.

Comment?

Related Topix: Biotech, Wockhardt, Fortis Healthcare, Healthcare Industry, Health Care Provider, Health

Tue Dec 08, 2009

Hindustan Times

Ranbaxy ends JV with Japanese firm

Pharma company Ranbaxy Laboratories on Tuesday said it has exited from Japan-based joint venture company--Nihon Pharmaceutical Industry.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Thu Nov 26, 2009

Business Standard

'China will snatch our market from us'

Atul Sobti took over as the chief executive officer and managing director at Ranbaxy Laboratories, six months ago.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, Food and Drug Administration

Fri Nov 20, 2009

Express India

Corporate Notes

The Financial Express Posted: Saturday, Nov 21, 2009 at 0050 hrs IST Updated: Saturday, Nov 21, 2009 at 0050 hrs IST : Ranbaxy recalls drugs from US market Ranbaxy Laboratories has recalled from the US market a batch of 4,348 cartons of Sotret Isotretinoin capsules used in treating skin infections.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry, Food and Drug Administration

Mon Nov 09, 2009

Mydigitalfc.com

Issues with USFDA to take long to resolve: Ranbaxy

Drug Administration to sort out issues related to generic drugs but the matter is likely to take long to resolve.

Comment?

Related Topix: Biotech, World News, India,

Mon Oct 26, 2009

The Hindu

Ranbaxy back in black

NEW DELHI: Riding on the back of consistent sales in emerging markets and cost cutting measures, Ranbaxy Laboratories on Monday posted a consolidated profit after tax of Rs.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Fri Oct 23, 2009

Express India

Badal asks Ranbaxy to add booster dose to state healthcare

Chandigarh: Punjab chief minister Parkash Singh Badal has asked Ranbaxy Laboratories Limited to prepare a comprehensive plan to undertake extensive research to study the root cause of the deadly diseases and suggest measures for their effective eradication to make Punjab, a disease-free state.

Comment?

Related Topix: Biotech

Fri Oct 09, 2009

Canada.com

Pfizer may make counter bid for Ranbaxy

Pfizer may bid for Ranbaxy Laboratories, countering a $4.6 billion offer by Japan's Daiichi Sankyo for the Indian generic drug maker, the Business Standard newspaper said.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry

Wed Oct 07, 2009

Expressindia

EU anti-trust raid on Ranbaxy France unit

New Delhi After facing a slew of troubles in the US market last year, the country's largest drug maker, Ranbaxy Laboratories Ltd, in which Daiichi Sankyo of Japan has a 64% stake, is in for some rude shock in Europe.

Comment?

Related Topix: World News, India, Biotech, Asia

Tue Oct 06, 2009

Express India

Ranbaxy to market Daiichi's products in Mexico

The Gurgaon-based drug firm would market the products through its Latin America-based subsidiary, Ranbaxy Mexico SA de CV Mexico.

Comment?

Related Topix: World News, India, Biotech,

Sat Sep 19, 2009

The Hindu

Ranbaxy to market Medy-Tox product

GURGAON: Ranbaxy Laboratories has entered into an in-licensing agreement with Medy-Tox, South Korea's Botulinum-Toxin specialised biotech venture, for the latter's cosmetic product, Neuronox.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Thu Sep 17, 2009

Mydigitalfc.com

Ranbaxy ties up with South Korean firm

Drug major Ranbaxy Laboratories has entered into a deal with South Korean biotech firm Medy-Tox for marketing its cosmetic product, Neuronox, in the Indian market.

Comment?

Related Topix: Biotech, Marketing

Tue Sep 01, 2009

Med Ad News

Daiichi Sankyo and Ranbaxy Leverage New Business Model with Launch of Evista in Romania

TOKYO, Gurgaon, India, September 1, 2009 - Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited announced today that Terapia S.A. , a subsidiary of Ranbaxy in Romania, will market the osteoporosis medication, Evista in Romania.

Comment?

Related Topix: Medicine, Evista, Raloxifene (generic), Medication, World News, India, Biotech, Osteoporosis, Health, Marketing

Wed Aug 12, 2009

Hindustan Times

Flu vaccine flies off the shelves

With the government indicating on Monday that it would soon procure 20 million capsules of the generic antiviral drug Tamiflu in the wake of the spread of swine flu, drug makers across the country including Ranbaxy, Cipla, Hetero and Roche are bracing themselves for a hike in production of the in-demand drug.

Comment?

Related Topix: Tamiflu, Oseltamivir (generic), Medicine, Medication, Influenza, Health, H1N1 Influenza / Swine Flu, Biotech, Ranbaxy Laboratories, Healthcare Industry

Domain-B

Swine flu bolsters Indian pharma stocks

Shares of Indian drug firms that make the generic version of Roche's Tamiflu, used to treat H1N1 flu, rose 5-19 per cent on Tuesday as the death toll from the pandemic in the country rose to ten.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Financial Markets, Tamiflu, Oseltamivir (generic), Medicine, Medication, Epidemic, Natural Disasters, Biotech

Fri Jul 24, 2009

The Age

India's Ranbaxy's Q2 profit soars but sees year loss

Top Indian generic drugs firm Ranbaxy Laboratories, a unit of Japan's Daiichi Sankyo, reported Friday net profit soared during the second quarter, swelled by foreign exchange gains.

Comment?

Related Topix: Biotech, World News, India, Food and Drug Administration

Tue Jul 21, 2009

Domain-B

Ranbaxy to market cholesterol-lowering drug in Canada

Ranbaxy Laboratories has received a final approval from from Health Canada, therapeutic products directorate to manufacture and market Ran-Simvastatin tablets in Canada.

Comment?

Related Topix: Biotech, Medicine, Ranbaxy Laboratories, Cholesterol, Healthcare Industry, Zocor, Simvastatin (generic), Medication

Mon Jun 01, 2009

The Telegraph

Dr Reddy's eyes prime position in US generics

Mumbai, May 31: Hyderabad-based Dr Reddy's Laboratories Ltd aims to be among the top five generic companies in the US by 2013, banking on an array of new drugs for which it is seeking permissions from American authorities.

Comment?

Related Topix: Biotech, Medicine, Dr Reddys Laboratories, Healthcare Industry, Ranbaxy Laboratories

Robbins Jobs

Also on Topix